Online Pharmaceutical Schedule - December 2021


You are viewing December 2021. View November 2021 Schedule.

Vaccinations
Influenza vaccine Inj 30 mcg in 0.25 ml syringe (paediatric quadrivalent vaccine); Inj 60 mcg in 0.5 ml syringe (quadrivalent vaccine); Inj 60 mcg in 0.5 ml syringe (adjuvanted quadrivalent vaccine); Inj 60 mcg in 0.5 ml syringe (paediatric quadrivalent vaccine)
Hepatitis B recombinant vaccine Inj 10 mcg per 0.5 ml prefilled syringe; Inj 20 mcg per 1 ml prefilled syringe
Diphtheria, tetanus, pertussis and polio vaccine Inj 30 IU diphtheria toxoid with 40 IU tetanus toxoid, 25 mcg pertussis toxoid, 25 mcg pertussis filamentous haemagglutinin, 8 mcg pertactin and 80 D-antigen units poliomyelitis virus in 0.5ml syringe
Haemophilus influenzae type B vaccine Haemophilus Influenzae type B polysaccharide 10 mcg conjugated to tetanus toxoid as carrier protein 20-40 mcg; prefilled syringe plus vial 0.5 ml
Measles, mumps and rubella vaccine Inj, measles virus 1,000 CCID50, mumps virus 5,012 CCID50, Rubella virus 1,000 CCID50; prefilled syringe/ampoule of diluent 0.5 ml
Pneumococcal (PCV13) conjugate vaccine Inj 30.8 mcg of pneumococcal polysaccharide serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F in 0.5ml syringe
Pneumococcal (PCV10) conjugate vaccine Inj 1 mcg of pneumococcal polysaccharide serotypes 1, 5, 6B, 7F, 9V, 14 and 23F; 3 mcg of pneumococcal polysaccharide serotypes 4, 18C and 19F in 0.5 ml prefilled syringe
Pneumococcal (PPV23) polysaccharide vaccine Inj 575 mcg in 0.5 ml prefilled syringe (25 mcg of each 23 pneumococcal serotype)
Diphtheria, tetanus and pertussis vaccine Inj 2 IU diphtheria toxoid with 20 IU tetanus toxoid, 8 mcg pertussis toxoid, 8 mcg pertussis filamentous haemagglutinin and 2.5 mcg pertactin in 0.5 ml syringe
Bacillus Calmette-Guerin vaccine Inj Mycobacterium bovis BCG (Bacillus Calmette-Guerin), Danish strain 1331, live attenuated, vial with diluent
Diphtheria, tetanus, pertussis, polio, hepatitis B and haemophilus influenzae type B vaccine Inj 30 IU diphtheria toxoid with 40 IU tetanus toxoid, 25 mcg pertussis toxoid, 25 mcg pertussis filamentous haemagglutinin, 8 mcg pertactin, 80 D-Ag U polio virus, 10 mcg hepatitis B surface antigen in 0.5 ml syringe
Poliomyelitis vaccine Inj 80D antigen units in 0.5 ml syringe
Hepatitis A vaccine Inj 1440 ELISA units in 1 ml syringe; Inj 720 ELISA units in 0.5 ml syringe
Meningococcal (groups A, C, Y and W-135) conjugate vaccine Inj 4 mcg of each meningococcal polysaccharide conjugated to a total of approximately 48 mcg of diphtheria toxoid carrier per 0.5 ml vial
Varicella vaccine [Chickenpox vaccine] Inj 1350 PFU prefilled syringe
Meningococcal C conjugate vaccine Inj 10 mcg in 0.5 ml syringe
Human papillomavirus (6, 11, 16, 18, 31, 33, 45, 52 and 58) vaccine [HPV] Inj 270 mcg in 0.5 ml syringe
Rotavirus oral vaccine Oral susp live attenuated human rotavirus 1,000,000 CCID50 per dose, prefilled oral applicator
Varicella zoster virus (Oka strain) live attenuated vaccine [shingles vaccine] Inj 19,400 PFU prefilled syringe plus vial
Meningococcal B multicomponent vaccine Inj 175 mcg per 0.5 ml prefilled syringe